David Michael Langenau
- Massachusetts General Hospital (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #4,553
- R01 Holder
- Early Career
- Mentor
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8873042Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0001-6664-8318Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$2.5M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#4,553
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing David Michael Langenau as a PI. Multi-PI records show the full award amount for context.
- 5R24OD031955-04R24Contact PIDeveloping preclinical xenograft models in zebrafish.$794.6Kaward amount
- 5R01CA269213-03R01Contact PIOncogenic Drivers of Rhabdomyosarcoma Cell State, Cancer Stem Cells and Metastasis$598.7Kaward amount
- $592.6Kaward amount
- 5R01CA276116-03R01Contact PIMechanisms of aggressive Rhabdomyosarcoma.$540Kaward amount
Award organization
Organizations that administered FY2025 awards listing David Michael Langenau as a PI.
FY2025 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #3915
- 2024Entered Top 25% NationallyRanked #3915
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding